Zhejiang Hisun Pharmaceutical Co. Ltd.   Report issue

Founded: Taizhou China (1956)

Organization Overview

First Clinical Trial
2013
NCT01998620
First Marketed Drug
2009
irinotecan (Camptosar)
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

HISUN PHARM HANGZHOU | Zhe Jiang Hisun Bioray Bio-pharmaceu tical Co.Ltd | ZHEJIANG HISUN PHARM | Zhejiang Hisun Pharmaceutical Co. Ltd. | Zhejiang Hisun Pharmaceuticals Co., Ltd